BioCentury
ARTICLE | Company News

Auguron Biosciences Inc., Lumera deal

February 4, 2008 8:00 AM UTC

Lumera’s Plexera Bioscience LLC subsidiary received exclusive rights to use Auguron’s Nucleic Acid Programmable Protein Array (NAPPA) technology on the Plexera Kx array platform for one year. Plexera ...